http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-025017-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef5bb7daa750911726614b1d85299995 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fede17decc5fa041cd3d25e6d6cc3104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9f37c66d5bbcb7ca21ba56de9d26c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b97de4f7ad62aa092db6c14dfe66e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efb1a42436852a6789cbb8022b43e22d |
| publicationDate | 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-025017-B1 |
| titleOfInvention | A METHOD FOR TREATING PATIENTS WITH THE HISTORY OF ATRIAL FIBRILLATION OR TORTUNICA TYPES OF THE APPLICATION OF THE APPRESSION OR OF EXISTING FIBRILLATION OF THE ATRIAL OR REPETITION OF PERMETRIUM WITH PREVENTION OF PERMS OF PERSONAL THERAPY OR EXPRESSION OF PERMS OF PREVENTION |
| abstract | This invention relates to a method of treating patients with a history of atrial fibrillation or atrial flutter, or existing atrial fibrillation or atrial flutter, preventing hospitalization in the cardiology department, including the administration of 800 mg dronedarone or its pharmaceutically acceptable salt, taken in one or more meals. morning and evening, and this drug is contraindicated for patients with severe heart failure, as indicated by any of the following symptoms: worsening symptoms of heart failure at rest or with minimal physical exertion, existing symptoms or a history of symptoms of congestive heart failure at rest, or symptoms of heart failure with minimal physical exertion within the last month, class IV NYHA, class III NYHA within the last months, recent decompensation, as evidenced by the need for hospitalization or intravenous therapy, recent decompensation requiring hospitalization or intravenous oh therapy for the treatment of heart failure. This method allows to reduce the frequency of hospitalizations in the cardiovascular department and reduce mortality in patients with associated risk factors. |
| priorityDate | 2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.